XML 134 R117.htm IDEA: XBRL DOCUMENT
v3.22.1

Employee Option Plans (Details) - USD ($) | 1 Months Ended | 12 Months Ended |  |
--- | --- | --- | --- | ---
Nov. 30, 2020 | Feb. 28, 2019 | Jan. 31, 2019 | Nov. 30, 2018 | Dec. 31, 2017 | Aug. 31, 2017 | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Aug. 03, 2021 | Feb. 06, 2020
Employee Option Plans (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |
Number of restricted shares (in Shares) |  |  |  |  |  |  |  |  |  | 24,222 |
Description of options vest |  |  |  |  |  |  | As of December 31, 2021, Formula’s chief financial officer holds 10,834 shares. |  |  |  |
Total fair value of grant |  |  |  |  |  |  | $ 50,054,000 |  |  |  |
Fair value of grant share price per share (in Dollars per share) |  |  |  |  |  |  | $ 81.8 |  |  |  |
Total equity-based compensation expense |  |  |  |  |  |  | $ 7,373,000 |  |  |  |
EBITDA percentage, description |  |  |  |  |  |  | (i) the EBITDA in the fiscal year immediately following the Specific Year was at least 110.25% of 75% of the Company’s EBITDA in the year preceding the Specific Year, or (ii) in case that the condition in the foregoing clause (i) was not met, then the EBITDA in the second fiscal year following the Specific Year was at least 115.7625% of 75% of the Company’s EBITDA in the year preceding the Specific Year. Accordingly, in case that either clause (i) or (ii) was met for a certain Specific Year, then the vesting with respect to such Specific Year shall be deemed to have been achieved, and those RSUs shall become vested as of the end of the Vesting Period. In the event that neither of the conditions described in clauses (i) or (ii) was met, the portion of RSUs for the applicable Specific Year shall automatically expire and terminate. |  |  |  |
Preceding years |  |  |  |  |  |  | 2 years |  |  |  |
Number of vested percentage |  |  |  |  |  |  | 20.00% |  |  |  |
Unrecognized compensation costs |  |  |  |  |  |  | $ 45,973,000 | $ 51,940,000 |  |  |
Selling, marketing, general and administrative expenses |  |  |  |  |  |  | 289,985,000 | 224,188,000 | $ 200,870,000 |  |
Unrecognized compensation cost |  |  |  |  |  |  | $ 393 |  |  |  |
Weighted average period |  |  |  |  |  |  | 1 year 3 months 14 days |  |  |  |
Matrix [Member] |  |  |  |  |  |  |  |  |  |  |
Employee Option Plans (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |
Description of options vest |  |  | Matrix approved, following the approval by Matrix’s compensation committee, the grant of 1,440,000 options which are exercisable into up to 1,440,000 ordinary shares of Matrix of NIS 1 par value each, to 20 senior officers of Matrix. The exercise price of the options was NIS 41.7 at the date of their grant, subject to adjustments, including upon the distribution of dividends. 50% of the options will be vested on January 1, 2021 with the remaining amount vesting in equal parts on January 1, 2022 and 2023. |  |  |  |  |  |  |  |
Unrecognized compensation costs |  |  |  |  |  |  | $ 1,368,000 | 428,000 |  |  |
Fair value options, exercise factor |  |  |  |  |  |  | 70.00% |  |  |  |
Fair value options, expected volatility |  |  |  |  |  |  | 24.00% |  |  |  |
Options expire periods |  |  |  |  |  |  | 5 years |  |  |  |
Sapiens [Member] |  |  |  |  |  |  |  |  |  |  |
Employee Option Plans (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |
Number of restricted shares (in Shares) |  |  |  |  |  |  |  |  |  |  | 173,005
Total equity-based compensation expense |  |  |  |  |  |  | $ 5,421,000 | $ 4,318,000 | $ 1,125,000 |  |
Unrecognized compensation costs |  |  |  |  |  |  | $ 8,072,000 |  |  |  |
Options expire periods |  |  |  |  |  |  | 4 years |  |  |  |
Employees and directors to purchase shares description |  |  |  |  |  |  | In 2019, 2020 and 2021, Sapiens granted 155,000, 315,000 and 847,000 stock options, respectively, to its employees and directors to purchase its shares. |  |  |  |
Weighted average grant date fair values of options (in Dollars per share) |  |  |  |  |  |  | $ 10.35 | $ 7.99 | $ 4.24 |  |
Intrinsic value of options exercised |  |  |  |  |  |  | $ 8,505,000 | $ 11,658,000 | $ 2,301,000 |  |
Selling, marketing, general and administrative expenses |  |  |  |  |  |  | 1,130,000 |  |  |  |
Magic [Member] |  |  |  |  |  |  |  |  |  |  |
Employee Option Plans (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |
Intrinsic value of options exercised |  |  |  |  |  |  | $ 628,000 | 765,000 | 537,000 |  |
Maximum [Member] |  |  |  |  |  |  |  |  |  |  |
Employee Option Plans (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |
EBITDA, percentage |  |  |  |  |  |  | 105.00% |  |  |  |
EBITDA decreasing, percentage |  |  |  |  |  |  | 75.00% |  |  |  |
Maximum [Member] | Matrix [Member] |  |  |  |  |  |  |  |  |  |  |
Employee Option Plans (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |
Fair value options, risk-free interest rate |  |  |  |  |  |  | 1.60% |  |  |  |
Minimum [Member] |  |  |  |  |  |  |  |  |  |  |
Employee Option Plans (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |
EBITDA, percentage |  |  |  |  |  |  | 75.00% |  |  |  |
EBITDA decreasing, percentage |  |  |  |  |  |  | 105.00% |  |  |  |
Minimum [Member] | Matrix [Member] |  |  |  |  |  |  |  |  |  |  |
Employee Option Plans (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |
Fair value options, risk-free interest rate |  |  |  |  |  |  | 0.50% |  |  |  |
General Assembly [Member] | Matrix [Member] |  |  |  |  |  |  |  |  |  |  |
Employee Option Plans (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |
Description of options vest |  | Matrix approved, after obtaining the approval of Matrix’s compensation committee and Matrix board of directors the grant of 80,000 options which are exercisable into up to 80,000 ordinary shares of Matrix of NIS 1 par value, to the President and Vice Chairman of the Matrix board. The exercise price of the options was NIS 43.16 at the date of their grant, subject to adjustments, including upon the distribution of dividends. 50% of the options will vest on January 1, 2021, with the remaining amount vesting in equal parts on January 1, 2022 and 2023. |  |  |  |  |  |  |  |  |
2011 Plan [Member] |  |  |  |  |  |  |  |  |  |  |
Employee Option Plans (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |
Number of restricted shares (in Shares) | 611,771 |  |  | 10,000 |  | 10,000 |  |  |  |  |
Description of options vest | 66.67% of the RSUs (i.e., 407,847 RSUs) are subject to time-based vesting that shall start as of the grant date and shall end at December 31, 2027, subject to the continued engagement of Formula’s chief executive officer with the Company as of that date (the “Vesting Period”); and up to 33.33% of the RSUs (i.e., 203,924 RSUs as of the date hereof) are subject to performance-based vesting, and shall vest at December 31, 2027 on a pro-rata basis with respect to each fiscal year (starting as of January 1, 2020) during the Vesting Period in which the Target EBITDA (as defined below) is achieved, subject to the continued engagement of Formula’s chief executive officer with the Company. At the end of the vesting period, the number of performances-based RSUs that vests shall be equal to (i) the number of fiscal years in which the Target EBITDA was achieved multiplied by (ii) 25,490.50 RSUs (rounded to the nearest whole number, up to a cap of 203,924 RSUs in total). The “Target EBITDA” in a given fiscal year during the Vesting Period means the Company’s EBITDA in that certain fiscal year (as reflected in the Company’s annual audited consolidated financial statements), excluding the cost attributed to the applicable portion of the RSUs in the Company’s annual audited consolidated financial statements for the applicable fiscal year (as to which the review of performance is made to determine whether one-eighth of the Performance Based RSUs (i.e., 25,490.50 RSUs) shall become vested at the end of the Vesting Period). |  |  | These restricted shares vest on an annual basis over a four-year period, commencing on November 19, 2018 and concluding on November 19, 2022, provided that during such time the chief operational officer will continue to serve as (i) an officer of the Company and/or (ii) an officer in one of the directly held affiliates. The total fair value of the grant was calculated based on the Formula share price on the grant date and equaled $382 ($38.2 per share). The total compensation expense the Company recorded in its statement of profit or loss for the years ended December 31, 2019, 2020 and 2021 were $191, $98 and $60, respectively. As of December 31, 2021 Formula’s chief operational officer holds 10,000 restricted shares from this grant, of which 7,500 are fully vested. |  | These restricted shares vest on a quarterly basis over a three-year period, commencing on August 17, 2017 and concluding on August 17, 2020, provided that during such time the chief financial officer will continue to serve as (i) an officer of the Company and/or (ii) an officer in one of the directly held affiliates, except that if he fails to meet the service condition due to the request of the board of directors of either Formula or any of its directly held affiliates (other than a termination of his provision of services which is based on actions or omissions by him that will constitute “cause” under his grant agreement with Formula), then, the chief financial officer will be deemed to have complied with clauses (i) or (ii) above. |  |  |  |  |
Total fair value of grant |  |  |  |  |  | $ 371,000 |  |  |  |  |
Fair value of grant share price per share (in Dollars per share) |  |  |  |  |  | $ 37.1 |  |  |  |  |
Total equity-based compensation expense |  |  |  |  |  |  |  | $ 21,000 | $ 66,000 |  |
Mr. Moti Gutman [Member] | Matrix [Member] |  |  |  |  |  |  |  |  |  |  |
Employee Option Plans (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |
Description of options vest |  |  |  |  | Matrix extended its agreement with Revava Management Company Ltd. through which its chief executive officer, Mr. Moti Gutman, provides services to Matrix, for five years’ term starting on January 1, 2018. As part of the new agreement in January 2018, Matrix awarded Mr. Gutman 256,890 (RSUs), which vest on an annual basis over a five-year period, commencing on January 16, 2018 and concludes on December 31, 2022, but not before the publication of Matrix’s financial statements for each respective year, and subject to certain conditions. In 2021, 51,378 restricted share units (RSU) were vested and exercised. As of December 31, 2021 Mr. Gutman holds 102,756 restricted share units (RSU) from this grant. |  |  |  |  |  |

X
- Definition The expected excercise of the share price used to calculate the fair value of the share options granted. + References No definition available. + Details
Name: | forty_DescriptionOfExerciseShareOptionsGranted
Namespace Prefix: | forty_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | forty_EarningsBeforeInterestTaxesDepreciationAndAmortizationDecreasingPercentage
Namespace Prefix: | forty_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Earnings before interest, taxes, depreciation, and amortization, percentage. + References No definition available. + Details
Name: | forty_EarningsBeforeInterestTaxesDepreciationAndAmortizationPercentage
Namespace Prefix: | forty_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Earnings before interest, taxes, depreciation and amortization percentage, description. + References No definition available. + Details
Name: | forty_EarningsBeforeInterestTaxesDepreciationAndAmortizationPercentageDescription
Namespace Prefix: | forty_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | forty_EmployeeOptionPlansDetailsLineItems
Namespace Prefix: | forty_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Fair value of grant share price per share. + References No definition available. + Details
Name: | forty_FairValueOfGrantSharePricePerShare
Namespace Prefix: | forty_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Intrinsic value of options exercised. + References No definition available. + Details
Name: | forty_IntrinsicValueOfOptionsExercised
Namespace Prefix: | forty_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- References No definition available. + Details
Name: | forty_NumberOfShareOptionGrantedInSharebasedPaymentArrangements
Namespace Prefix: | forty_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of vested percentage. + References No definition available. + Details
Name: | forty_NumberOfVestedPercentage
Namespace Prefix: | forty_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Options expire periods. + References No definition available. + Details
Name: | forty_OptionsExpirePeriods
Namespace Prefix: | forty_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Preceding years. + References No definition available. + Details
Name: | forty_PrecedingYears
Namespace Prefix: | forty_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of restricted shares. + References No definition available. + Details
Name: | forty_RestrictedShares
Namespace Prefix: | forty_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Unrecognized compensation cost. + References No definition available. + Details
Name: | forty_UnrecognizedCompensationCost
Namespace Prefix: | forty_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- Definition Unrecognized compensation costs. + References No definition available. + Details
Name: | forty_UnrecognizedCompensationCosts
Namespace Prefix: | forty_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Weighted average grant date fair values of options. + References No definition available. + Details
Name: | forty_WeightedAverageGrantDateFairValuesOfOptions
Namespace Prefix: | forty_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | forty_WeightedAveragePeriod
Namespace Prefix: | forty_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2021-01-01 -Paragraph 47 -Subparagraph a -Clause i -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_47_a_i&doctype=Standard -URIDate 2021-03-24 + Details
Name: | ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted
Namespace Prefix: | ifrs-full_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2021-01-01 -Paragraph 47 -Subparagraph a -Clause i -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_47_a_i&doctype=Standard -URIDate 2021-03-24 + Details
Name: | ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted
Namespace Prefix: | ifrs-full_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The description of the vesting requirements for a type of share-based payment arrangement that existed at any time during the period. An entity with substantially similar types of share-based payment arrangements may aggregate this information. [Refer: Share-based payment arrangements [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2021-01-01 -Paragraph 45 -Subparagraph a -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_a&doctype=Standard -URIDate 2021-03-24 + Details
Name: | ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of compensation to key management personnel in the form of share-based payments. [Refer: Key management personnel of entity or parent [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 24 -IssueDate 2021-01-01 -Paragraph 17 -Subparagraph e -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_17_e&doctype=Standard -URIDate 2021-03-24 + Details
Name: | ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of expense relating to selling, general and administrative activities of the entity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2021-01-01 -Paragraph 85 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_85&doctype=Standard -URIDate 2021-03-24 + Details
Name: | ifrs-full_SellingGeneralAndAdministrativeExpense
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The weighted average fair value of share options granted during the period at the measurement date. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2021-01-01 -Paragraph 47 -Subparagraph a -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_47_a&doctype=Standard -URIDate 2021-03-24 + Details
Name: | ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Details
Name: | forty_PlanOfNameAxis=forty_MatrixMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | forty_PlanOfNameAxis=forty_SapiensMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | forty_PlanOfNameAxis=forty_MagicMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=forty_GeneralAssemblyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | forty_EmployeeOptionPlansAxis=forty_TwoThousandElevenPlanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | forty_EmployeeOptionPlansAxis=forty_GutmanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |